Hydroxy-chloroquine approved for asymptomatic household contacts of laboratory-confirmed COVID-19 patients:
Amid rising coronavirus cases in India, the national task force for COVID-19 constituted by the Indian Council for Medical Research (ICMR) has recommended hydroxychloroquine as a preventive medication for high-risk populations.
According to this advisory distributed from New Delhi on March 22, 2020, hydroxy-chloroquine should be given to high-risk population — asymptomatic healthcare workers involved in the care of suspected or confirmed cases of COVID-19 disease and asymptomatic household contacts of laboratory-confirmed cases.
The hydroxy-chloroquine protocol recommended by the National Task Force has been approved by the Drug Controller General of India (DGCI) for restricted use in emergency situations.
“Hydroxy-chloroquine is found to be effective against coronavirus in laboratory studies and in-vivo studies. Its use in prophylaxis is derived from the available evidence of benefit as treatment and supported by preclinical data,” the advisory said.